Introduction {#sec1}
============

Supramolecular assemblies of polypeptides have found utility in many applications including drug delivery^[@ref1]^ and tissue regeneration.^[@ref2]^ The repertoire of chemical functional groups available in the side chains of natural and synthetic amino acid building blocks, combined with well-defined conformation of the peptide backbone, has led to a plethora of self-assembled peptide nanostructures, such as spheres,^[@ref3]^ fibrils,^[@ref4]^ sheets,^[@ref5]^ hollow vesicles,^[@ref6]^ nanotubes,^[@ref7]^ and networks.^[@ref8]^ Despite this expansion, the understanding of the morphogenesis of these assemblies still remains inadequate to predict and control their morphology through tailoring their chemical structures and manipulating the environmental conditions.^[@ref9]^

The rational design of peptides for self-assembly involves consideration of various factors, such as inter-/intramolecular hydrogen bonds, hydrophobic effects, electrostatic forces, van der Waals' interactions, and dipole--dipole interactions arising from the chemical structures.^[@ref10]^ While helices emerge from intramolecular H-bonds, β-structures engage interchain backbone hydrogen bonds between peptide strands and dominate as a self-assembling peptide motif.^[@ref11]^ Variation of charge and hydrophobicity of peptide side chains provide additional repertoire for designing peptides to grow into extended β-sheets.^[@ref12],[@ref13]^ The PPII helix form that is prevalent in polyproline and collagen peptides can be used as a versatile scaffold to arrange charged hydrophilic and neutral hydrophobic groups at specific positions along the helix.^[@ref14]−[@ref19]^ Several design strategies have been implemented for hierarchical self-assembly of collagen mimetic peptides to yield morphologically well-defined nanostructures. These include the use of metal ions to generate cagelike hollow structures by collagenous peptides bearing metal-binding ligands^[@ref16]^ and the use of electrostatic interactions between negatively and positively charged amino acid residues.^[@ref17]^ By employing the latter strategy, a variety of morphologies, such as nanofibers,^[@ref18]^ hydrogels,^[@ref19]^ and nanosheets,^[@ref20]^ have been created by placing different amino acids at strategic positions along the PPII chains in the collagen triple helices to induce favorable intermolecular salt bridges. Polyproline peptides are also amenable to stereospecific modifications, in particular at C4, to provide a platform to spatially organize functional groups at regular intervals along a PPII helix.^[@ref21]^ Such peptides have been shown to assemble into fibers or into an exquisite molecular interlace.^[@ref22],[@ref23]^

We have earlier demonstrated solvent-dependent changes of conformation from a PPII helix in aqueous (aq) phosphate buffer to a β-structure in trifluoroethanol (TFE) in polypeptides derived from *cis*-(2*S*,4*S*)-hydroxy/amino-[l]{.smallcaps}-proline ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A).^[@ref24],[@ref25]^ The two strands of the β-sheet-like structure observed in TFE were shown to be aligned in an antiparallel orientation.^[@ref25]^ The *cis*-(2*S*,4*S*)-4-hydroxy-[l]{.smallcaps}-prolyl polypeptide ([l]{.smallcaps}~C~-*Hyp*)~9~ forms a β-structure upon conjugation with the C~12~--C~16~ chain at the N-terminus and does not show any regular morphology in water but assembles into long nanofibers in TFE.^[@ref25]^ The *R*/*S* stereochemical nature of C4--(OH/NH~2~) substitution on [l]{.smallcaps}-proline is crucial in influencing the conformation adopted by the polypeptides; only the *cis*-(2*S*,4*S*) disposition of C2 and C4 substituents on [l]{.smallcaps}-proline ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A) leads to a β-sheet-like structure in TFE. The *trans*-(2*S*,4*R*) orientation of substituents ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B) failed to show the β-sheet-like structure and formed only the PPII structure in TFE. In this context, it would be interesting to study the generality of conformational features in 4-substituted [l]{.smallcaps}/[d]{.smallcaps}-prolyl polypeptides corresponding to all four diastereomers ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Herein, we examine the comparative conformational features of the 4(NH~2~/OH) substituents on [l]{.smallcaps}/[d]{.smallcaps}-prolines in both homochiral (all-[l]{.smallcaps} or all-[d]{.smallcaps}prolyl units) and heterochiral (alternating [l-]{.smallcaps} and [d]{.smallcaps}-prolyl units) polypeptides and the role of conformation in solution in the associated morphology arising from self-assembly. It was found that the β-sheet-like structure in TFE resulted from homochiral [l]{.smallcaps}- and [d-]{.smallcaps}polypeptides containing cis-2,4-disubstituted scaffolds. On the other hand, in heterochiral polypeptides with backbone having alternating [l]{.smallcaps}/[d]{.smallcaps}-prolyl units, the same β-sheet-like structure was formed by the trans-2,4-disubstituted scaffolds.

![Structures of polyproline peptides. (A) *cis*-(2*S*,4*S*)-[l]{.smallcaps}-Prolyl ([l]{.smallcaps}~C~), (B) *trans*-(2*S*,4*R*)-[l]{.smallcaps}-prolyl ([l]{.smallcaps}~T~), (C) *cis*s-(2*R*,4*R*)-[d]{.smallcaps}-prolyl ([d]{.smallcaps}~C~), and (D) *trans*-(2*R*,4*S*)-[d]{.smallcaps}-prolyl ([d]{.smallcaps}~T~) polypeptides.](ao0c02826_0002){#fig1}

Results and Discussion {#sec2}
======================

Synthesis of 4(*R*/*S*)-Amino-[l]{.smallcaps}/[d]{.smallcaps}-prolyl Polypeptides {#sec2.1}
---------------------------------------------------------------------------------

Fmoc-protected prolines **1** and **2**, along with the two sets of four diastereomers each from 4(*R*/*S*)-amino-[l]{.smallcaps}/[d]{.smallcaps}-proline (**3**--**6**) and 4(*R*/*S*)-hydroxy-[l]{.smallcaps}/[d]{.smallcaps}-proline (**7**--**10**) ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) were used for the synthesis of homo- and heterochiral polypeptides. The monomers **1**, **2**, and **7** were obtained from commercial sources, and the monomers **3**, **4**, **5**, **8**, and **9** were synthesized following the procedures reported earlier.^[@ref25]−[@ref27]^ The [d]{.smallcaps}-monomers (4*R*)-*N*^4^(Boc)-*N*1(Fmoc)-[d]{.smallcaps}-*Amp* (**6**) and (4*R*)-*O*^4^(*t*Bu)-*N*1(Fmoc)-[d]{.smallcaps}-*Hyp* (**10**) were synthesized as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, starting from the (4*R*)-OH-*N*1(Cbz)-[d]{.smallcaps}-*Pro*-methyl ester (**11**), which was reported previously.^[@ref27]^ The methyl ester **11** was treated with methyl *p*-toluenesulfonate under Mitsunobu reaction conditions to obtain (4*S*)-OTs derivative **12**, followed by the reaction with NaN~3~ accompanied by re-inversion at C4 to yield (4*R*)-N~3~ compound **13** that showed a characteristic IR stretching frequency for the azide at 2104 cm^--1^. The azide **13** was reduced by the Staudinger reaction to obtain the (4*R*)-NH~2~ derivative, which was in situ protected as its Boc derivative to yield (4*R*)-*N*^4^(Boc)-[d]{.smallcaps}-*Pro* methyl ester **14**. Hydrolysis of the ester **14** with aq LiOH and deprotection of N1(Cbz) by hydrogenation followed by reprotection to the *N*^1^-Fmoc derivative yielded monomer **6**. For the preparation of **10**, the reaction of **11** with *tert*-butyl bromide to yield 4*R* (*O*^4^-*tert*-butyl) ether **15** was followed by the same sequence of hydrolysis and reductive deprotection and Fmoc protection to afford the final compound. All synthesized monomers were characterized by their NMR and mass spectral data, and the chiral purities of **4** and **6** were confirmed by chiral high-performance liquid chromatography (HPLC). While [l]{.smallcaps}-monomers were synthesized as Boc derivatives (**3** and **5**), [d]{.smallcaps}-monomers were synthesized as Fmoc derivatives (**4** and **6**). For determining the chiral purity, the corresponding enantiomeric pairs **4e** and **6e** were synthesized. The chromatogram revealed that the two [d]{.smallcaps}-diastereomeric monomers (**4** and **6**) clearly resolved from their respective [l]{.smallcaps}-enantiomers (**4e** and **6e**), each exhibiting unique retention times, with no contamination from other diastereomers ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information).

![Structures of protected [l]{.smallcaps}- and [d]{.smallcaps}-prolines (**1** and **2)**, diastereomeric 4(*R*/*S*)-amino-[l]{.smallcaps}/[d]{.smallcaps}-prolines (**3**--**6**) and 4(*R*/*S*)-hydroxy-[l]{.smallcaps}/[d]{.smallcaps}-prolines (**7**--**10**).](ao0c02826_0003){#fig2}

![Synthesis of (4*R*)-*N*^4^(Boc)-*N*1(Fmoc)-[d]{.smallcaps}-*Amp* (**6**) and (4*S*)-*O*^4^-*t*Bu-*N*^1^-Fmoc-[d]{.smallcaps}-*Hyp* (**10**)\
(a) PPh~3~, diisopropyl azodicarboxylate (DIAD), methyl *p*-toluenesulfonate, dry tetrahydrofuran (THF) (56%); (b) NaN~3~, 60 °C, dimethylformamide (DMF), 3 h (73%); (c) PPh~3~, dry THF; (d) (Boc)~2~O, dioxane/water (50:50) (93%); (e) 2 N aq LiOH; (f) H~2~, Pd/C, methanol; (g) Fmoc-Cl, 10% aq Na~2~CO~3~, dioxane/water (50:50) (50%). (h) *t*Bu-Br, Ag~2~O (90%); (i) 2 N LiOH; (j) H~2~, Pd/C; (k) Fmoc-Cl, 10% Na~2~CO~3~ (50%).](ao0c02826_0016){#sch1}

The protected monomers (**1**--**10**) were used for the synthesis of polypeptides **P1**--**P12** on a solid support (4-methyl benzhydrylamine (MBHA) or Rink amide resin) using either *t*-Boc (for **P2** and **P3**) or Fmoc chemistry (for **P1** and **P4**--**P12**) following standard protocols.^[@ref28]−[@ref30]^ The sequences of various homochiral (all-[l]{.smallcaps}, **P1**--**P5**, and all-[d]{.smallcaps}, **P6**--**P10**) and heterochiral (alternating [l]{.smallcaps}/[d]{.smallcaps}, **P11** and **P12**) polypeptides synthesized are shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. The [l]{.smallcaps}- and [d]{.smallcaps}-peptides were capped at the N-terminus by [l]{.smallcaps}- or [d]{.smallcaps}-phenylalanine, respectively, to enable the measurement of peptide concentrations using their extinction coefficients at 257 nm (195 M^--1^ cm^--1^).^[@ref31]^ Tyrosine or tryptophan has a better extinction coefficient than phenylalanine but were not preferred at the N-terminus to avoid their effects on peptide folding. Tyrosine with phenolic hydroxyl and the indole ring in tryptophan may be active in imparting H-bonding and aromatic stacking at the N-terminus to influence the chirality of peptide chains. All peptides were purified by HPLC, and their identity was established by mass spectral data ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information).

![Structures of prolyl polypeptides. **P1**--**P5**: [l]{.smallcaps}-(2*S*)-homopolypeptides; **P6**--**P10**: [d]{.smallcaps}-(2*R*)-homopolypeptides; **P11**: heterochiral, alternating, all-*cis* \[[l]{.smallcaps}~C~--[d]{.smallcaps}~C~\]-polypeptide; **P12**: heterochiral, alternating, all-*trans* \[[l]{.smallcaps}~T~--[d]{.smallcaps}~T~\] polypeptide; and **P13**: [l]{.smallcaps}-Phe-\[[l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro\]~4~-[l]{.smallcaps}-Pro.](ao0c02826_0004){#fig3}

Circular Dichroism (CD) Conformational Studies of Homochiral Enantiomeric [l]{.smallcaps}~C~-*Amp*~9~ and [d]{.smallcaps}~C~-*Amp*~9~ Polypeptides {#sec2.2}
--------------------------------------------------------------------------------------------------------------------------------------------------

[Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A shows the CD spectra of unsubstituted prolyl enantiomeric peptides [l]{.smallcaps}-*Pro*~9~ (**P1**) and [d]{.smallcaps}-*Pro*~9~ (**P6**) in phosphate buffer and trifluoroethanol (TFE). The CD spectra are exact mirror images as expected for true enantiomers, and no changes in the conformation of peptides were seen in the two solvents. The 4-amino-substituted homochiral enantiomeric peptides [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) showed CD spectra in buffer with bands at 225 and 205--207 nm corresponding to the n → π\* and π → π\* transitions of the peptide bonds^[@ref32]^ ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B). The CD spectra were mirror images with respect to signs of the bands but not exactly with respect to the intensities: the [l]{.smallcaps}-peptide **P3** had a slightly higher intensity at the 205--207 nm region than the [d]{.smallcaps}-peptide **P8**. The conformational profile of [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) in buffer is typical of left-handed PPII (similar to **P1**)^[@ref32]^ and hence the mirror image CD spectral profile of enantiomeric [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) (similar to [d]{.smallcaps}-*Pro*~9~**P6**) represents a right-handed PPII form. This is consistent with an earlier observation that has reported mirror image CD spectra for [d]{.smallcaps}-proline.^[@ref33]^ The CD spectra of enantiomeric peptides [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) in TFE are shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C. [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) exhibited a large negative band at 220 nm arising from the n → π\* transition, with the appearance of a large positive band at 197 nm and disappearance of the mild positive band at 225 nm. This profile is characteristic of a β-sheet-like structure with a right-handed twist as established before.^[@ref34]^ The CD spectra of enantiomeric [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) showed an inversion in the sign of bands, with a strong positive band at 215 nm and a negative band at 197 nm representing a mirror image β-sheet-like structure with a left-handed twist, which is unknown in the literature. Although mirror images in terms of their sign, the CD spectra of **P3** and **P8** in TFE are not exactly mirror images in terms of intensities and depict slight asymmetry in their band positions ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). In view of the fact that unsubstituted [l]{.smallcaps}-*Pro*~9~ (**P1**) and [d]{.smallcaps}-*Pro*~9~ (**P6**) peptides have exact mirror image CD profiles in both aqueous phosphate buffer and TFE, the slight asymmetric effects seen in CD spectra of **P3** and **P8** point to subtle conformational differences induced by the C4-amino substituent at the microstructural level.

![CD spectra of enantiomeric peptide pairs in phosphate buffer and TFE. (A) [l]{.smallcaps}-*Pro*~9~ (**P1**), phosphate (black) and TFE (red); [d]{.smallcaps}-*Pro*~9~ (**P6**), phosphate buffer (blue) and TFE (green). (B) [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) in phosphate buffer and (C) [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) in TFE. All spectra were recorded at a peptide concentration of 200 μM.](ao0c02826_0005){#fig4}

Conversely, the CD spectra of enantiomeric *trans* peptides [l]{.smallcaps}~T~-*Amp*~9~ (**P2**) and [d]{.smallcaps}~T~-*Amp*~9~ (**P7**) were similar in aqueous phosphate buffer and TFE. They exhibited CD bands that were relatively weaker for the n → π\* transition at 220--225 nm and a stronger band for the π → π\* transition at 200--205 nm ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). These bands were of opposite sign, and [d]{.smallcaps}~T~-*Amp*~9~ (**P7**) showed lower-intensity bands than the enantiomeric peptide [l]{.smallcaps}~T~-*Amp*~9~ (**P2**) in both buffer and TFE. The CD profiles of *trans* peptides [l]{.smallcaps}~T~-*Amp*~9~ (**P2**) and [d]{.smallcaps}~T~-*Amp*~9~ (**P7**) in TFE indicated non-formation of the β-structure by either in TFE.

CD Conformational Studies of Homochiral Enantiomeric [l]{.smallcaps}~C~-*Hyp*~9~ and [d]{.smallcaps}~C~-*Hyp*~9~ Polypeptides {#sec2.3}
-----------------------------------------------------------------------------------------------------------------------------

As reported earlier,^[@ref25]^ the [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) peptide showed a PPII conformation in buffer and β-sheet-like CD spectra in TFE with a negative band at around 212 nm and a positive band at around 195 nm ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A,B). The enantiomeric peptide [d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) showed almost perfect mirror image CD spectra in aqueous phosphate buffer ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A), and in TFE, the spectra showed inversion of bands at almost similar wavelength, but the intensity of the positive band at 215 nm was significantly larger. The disparity of CD band intensities in enantiomeric peptides in [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) and [d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) was qualitatively similar to that seen in enantiomeric [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C) and largely amplified in TFE, with [d]{.smallcaps}-peptide showing higher intensity than [l]{.smallcaps}-peptide.

![CD spectra of enantiomeric peptide pairs [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) and [d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) in buffer (A) and TFE (B). All spectra were recorded at a peptide concentration of 200 μM.](ao0c02826_0006){#fig5}

The *trans*-[l]{.smallcaps}~T~-*Hyp*~9~ (**P4**) and [d]{.smallcaps}~T~-*Hyp*~9~ (**P9**) polypeptides in aqueous phosphate buffer showed CD spectra with inversion in sign of bands at 225 and 205--207 nm ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information), with the CD profile of [l]{.smallcaps}-peptide **P4** characteristic of the left-handed PPII conformation.^[@ref32]^ Thus, the mirror image CD profile of [d]{.smallcaps}-peptide **P9** corresponds to the right-handed PPII conformation. Although such inversion is established in unsubstituted [d]{.smallcaps}-proline polypeptides,^[@ref33]^ it is unknown in 4-substituted [d]{.smallcaps}-prolyl peptides. However, in TFE, both [l]{.smallcaps}~T~- and [d]{.smallcaps}~T~-*Hyp*~9~ peptides did not exhibit a β-sheet-like CD profile seen with the corresponding *cis*-[l]{.smallcaps}~C~- and [d]{.smallcaps}~C~-*Hyp*~9~ peptides^[@ref25]^ and retained their PPII conformation with minor differences in band intensities.

As seen from the above discussion, the 4-NH~2~/OH-substituted homochiral prolyl polypeptides (**P3**/**P8**; **P5**/**P10**) show a β-like structure in TFE only when the substituents at C2 and C4 (NH~2~/OH) are cis in relative orientation (2*S*,4*S* for [l]{.smallcaps}~C~ and 2*R*,4*R* for [d]{.smallcaps}~C~-prolyl polypeptides). The trans-substituted [l]{.smallcaps}/[d]{.smallcaps}-prolyl polypeptides (2*S*,4*R*; [l]{.smallcaps}~T~, **P2/P7**; [d]{.smallcaps}~T~, **P4/P9**) yielded only the PPII form in both aqueous phosphate buffer, and TFE and no β-sheet-like structure in TFE was seen, unlike that of [l]{.smallcaps}~C~/[d]{.smallcaps}~C~-peptides. This unambiguously suggested the importance of relative stereochemistry at both C2 and C4 for formation of β-sheet-like structures from all diastereomers of 4-substituted prolyl peptides.

CD Conformational Studies of Alternating Heterochiral \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ and \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~*Hyp*~9~ Polypeptides {#sec2.4}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In view of the unique properties exhibited by homochiral 4-NH~2~/OH cis-substituted [l]{.smallcaps}~C~*-* and [d]{.smallcaps}~C~-polypeptides, it was thought to assess heterochiral alternating [l-]{.smallcaps} and [d-]{.smallcaps}*Hyp*~9~ polypeptides \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ (**P11**) and \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**). The CD spectra of alternating \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ (**P11**) ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A) showed a strong negative CD band at 208 nm in phosphate buffer, an intense negative CD band at 215 nm in TFE, and absence of any band at higher wavelength. This indicates a random conformation, in contrast to ordered structures of homochiral all-*cis*[l]{.smallcaps}~C~-*Amp*~9~ (**P3**)/[l]{.smallcaps}~C~-*Hyp*~9~ (**P8**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P5**)/[d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) polypeptides that assumed a PPII form in phosphate buffer and a β-sheet-like structure in TFE.

![CD spectra of alternating heterochiral hydroxyprolyl polypeptides (A) \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ (**P11**), (B) \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**), and (C) \[[l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro\]~4~[l]{.smallcaps}-Pro (**P13**) in buffer (black) and TFE (red). [l]{.smallcaps}~C~ = *cis*-(2*S*,4*S*), [d]{.smallcaps}~C~ = *cis*-(2*R*,4*R*), [l]{.smallcaps}~T~ = *trans*-(2*S*,4*R*), and [d]{.smallcaps}~T~ = *trans*-(2*R*,4*S*).](ao0c02826_0007){#fig6}

The heterochiral *trans* peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) in buffer showed a moderately positive band at 195 nm, a strong negative CD band at 207 nm, and a weak positive CD band at 225 nm, indicative of a left-handed PPII structure ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B), characteristic of [l]{.smallcaps}-polypeptides ([l]{.smallcaps}~C~-*Amp*~9~ (**P3**)/[l]{.smallcaps}~C~-*Hyp*~9~ (**P5**)). In TFE, **P12** showed a negative band at 200 nm and a strong positive band at 218 nm, similar to the characteristic β-sheet-like structure of [d]{.smallcaps}-polypeptides **P8** and **P10**. Thus, in the alternating heterochiral *trans* peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**), the left-handed [l]{.smallcaps}-PPII structure seen in buffer assumes a right-handed twisted [d]{.smallcaps}-β-structure in TFE. In heterochiral peptides, the determinant for handedness of PPII in buffer seems to be the [l]{.smallcaps}-proline, while in TFE, the handedness of the twisted β-structure seems to be directed by [d]{.smallcaps}-proline. The molecular origin of differential adoption of handedness in the PPII conformation and twisted β-sheet-like structures cannot be deciphered from the present work.^[@ref35]^ What is interesting is the fact that homochiral ([l]{.smallcaps}~C~ and [d]{.smallcaps}~C~) polypeptides show a β-structure in TFE, while with alternating heterochiral peptides ([l]{.smallcaps}~T~--[d]{.smallcaps}~T~), it is the *trans* peptide that forms the β-structure.

The heterochiral polyproline \[[l]{.smallcaps}--[d]{.smallcaps}\]*~n~* peptides with alternating [l]{.smallcaps}/[d]{.smallcaps} configurations are reported to adopt conformations other than typical PPI and PPII in water, depending on the [l]{.smallcaps}/[d]{.smallcaps} nature of N-terminus amino acid.^[@ref36]^ When peptide length *n* is odd (N-terminus [l]{.smallcaps}), the CD spectra resemble the [l]{.smallcaps}-β-structure, and with number of residues *n* even (N-terminus [d]{.smallcaps}), the peptide has an undefined or a random conformation. This arises from the tendency of the [l]{.smallcaps}-Pro--[d]{.smallcaps}-Pro peptide amide bonds to adopt alternating trans and cis geometries at [l]{.smallcaps}--[d]{.smallcaps} and [d]{.smallcaps}--[l]{.smallcaps} steps.^[@ref36],[@ref37]^ The peptide [l]{.smallcaps}-Phe-([l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro)-[l]{.smallcaps}-Pro (**P13**) exhibited a CD spectrum typical of the left-handed PPII form similar to that of [l]{.smallcaps}-*Pro*~9~ (**P1**) ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}), which has all amides in trans form. The observed CD profile is thus dictated by the C-terminus [l]{.smallcaps}-Pro. In TFE, the peptide **P13** adopted a [l]{.smallcaps}-β-like conformation with resemblance to the CD pattern reported for \[[l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro\]*~n~*-[l]{.smallcaps}-Pro in water.

Given this solvent-dependent conformational behavior of heterochiral unsubstituted poly([l]{.smallcaps}--[d]{.smallcaps}) proline peptides, the interpretation of the conformational properties of alternating 4-*R*/*S*-substituted peptides is complex due to superimposition of chiral effects at both the backbone and side chains (C4) on the overall conformation of the peptide in TFE. The CD spectrum of *trans*-\[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) recorded in TFE ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}) suggests that in 4*-*Hyp peptides with an alternating [l]{.smallcaps}--[d]{.smallcaps} backbone, the handedness of β-structure is dominated by the [d]{.smallcaps}-Hyp residues rather than [l]{.smallcaps}-Hyp. In *cis*-\[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ (**P11**), the conformation adopted by the peptide is random (lack of 215 nm band) in both aqueous phosphate buffer and TFE ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). These effects perhaps arise from unfavorable combinations of *cis*/*trans*-prolyl amide bonds on the backbone ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### CD Spectral Features of Heterochiral Polyprolyl Peptides in Buffer and TFE

  peptide                                                                                                                                     water/PBS                           TFE                      remarks
  ------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------- ------------------------ ----------------------------------------------------------
  \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ (**P11**)[a](#t1fn1){ref-type="table-fn"}                                     190 nm (slightly +ve)               190 nm (+ve)             unfavorable *cis*--*trans*-amide geometry
                                                                                                                                              205--210 nm (−ve)                   215 nm (−ve)             
                                                                                                                                              random/undefined                    random/undefined         
  \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**)[a](#t1fn1){ref-type="table-fn"}                                     190--195 nm (+ve)                   195 nm (+ve)             all-*trans*-amide bonds in both phosphate buffer and TFE
                                                                                                                                              205--210 nm (−ve)                   200 nm (−ve)             
                                                                                                                                              225 nm (+ve)                        220 nm (+ve)             
                                                                                                                                              left-handed, [l]{.smallcaps}-PPII   [d]{.smallcaps}-β-like   
  \[[l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro\]~4~-[l]{.smallcaps}-Pro (**P13**)[a](#t1fn1){ref-type="table-fn"}                                190--195 nm (+ve)                   195 nm (+ve)             alternating *cis*--*trans*-amide bonds
                                                                                                                                              205--210 nm (−ve)                   212 nm (−ve)             
                                                                                                                                              225 nm (+ve)                                                 
                                                                                                                                              left-handed, [l]{.smallcaps}-PPII   [l]{.smallcaps}-β-like   
  Boc-\[[l]{.smallcaps}-Pro-[d]{.smallcaps}-Pro\]*~n~*-[l]{.smallcaps}-Pro (*n* = 1--3)[b](#t1fn2){ref-type="table-fn"}                       195 nm (+ve)                                                 alternating *cis*--*trans*-amide bonds
                                                                                                                                              215--220 nm (−ve)                                            
                                                                                                                                              [l]{.smallcaps}-β-like                                       
  Boc-\[[d]{.smallcaps}-Pro-[l]{.smallcaps}-Pro\]*~n~*-[d]{.smallcaps}-Pro-[l]{.smallcaps}-Pro (*n* = 1--3)[b](#t1fn2){ref-type="table-fn"}   190 nm (nearly zero)                                         alternating *cis*--*trans*-amide bonds
                                                                                                                                              210 nm (−ve)                                                 
                                                                                                                                              random/undefined                                             

Present work.

Data from ref ([@ref36]); PBS: phosphate-buffered saline, 10 mM, pH 7.0; TFE: trifluoroethanol.

Role of TFE and β-Structure Formation {#sec2.5}
-------------------------------------

It is well established that trans [l]{.smallcaps}~T~-*Amp*~9~ (**P2**) and [l]{.smallcaps}~T~-*Hyp*~9~ (**P4**) polypeptides adopt the PPII conformation in aqueous solvents with prolyl rings in the C4-*exo* conformation^[@ref38]^ ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A). It is stabilized by secondary factors such as stereoelectronic effects, N1-C4 gauche effects, and n−π\* interactions from N1-tertiary amide carbonyl to C2 carbonyl.^[@ref29],[@ref38]^ The *cis*-[l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) peptides show the PPII conformation with prolyl ring assuming C4-*endo* pucker ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}B,D).^[@ref39]^ In this conformation, the (4*S*)-(OH/NH~2~) substituent is favorably placed for intramolecular H-bonding with C2 amide carbonyl, retaining the stabilizing effects of n−π\* interactions. The cis disposition of C4 and C2 substituents allows intramolecular H-bonding between them, unlike that in the trans [l]{.smallcaps}~T~-substituted prolyl peptide ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A) where the C2 and C4 substituents are oriented in opposite directions. Both 4*S*- and 4*R*-substituted [l]{.smallcaps}-prolyl polypeptides adopt the PPII conformation in aqueous phosphate buffer. TFE as a solvent is generally known to stabilize the α-helix in peptides.^[@ref40]^ The bulk dielectric constant for pure TFE is about one-third that of water, and it is a much weaker hydrogen-bond acceptor (less negative charge on O due to vicinal electron-withdrawing CF~3~) but relatively a better H-bond donor than water.^[@ref41]^ The polar hydrophobicity of TFE (due to CF~3~) changes the water structure, leading to hydrophobic dehydration ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}C). The higher H-bonding donor ability of the OH group of TFE results in its complexation with the 2*S*-carbonyl group, hampering its intraresidue H-bonding with the (4*S*)-(NH~2~/OH) group ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}C). The loss of H-bonding and interfering steric effects of the CF~3~ group flips the C4-*endo* pucker of proline to C4-*exo* pucker, pushing the (4*S*)-NH~2~/OH group into a pseudo-equatorial position, where it is now available for possible interchain H-bonding to generate a β-structure ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}E). Such proline ring puckering to accommodate solvent effects is reasonable as ring pucker interconversion at room temperature has a low activation barrier of 2--5 kcal/mol with time scales of picoseconds,^[@ref42]^ while *trans*--*cis* amide bond conversion has a higher activation barrier ∼20 kcal/mol with time scales of seconds to minutes at room temperature.^[@ref43]^

![Schematic diagrams of proline puckering in *cis*-(2*S*,4*S*) peptides **P3** (X=NH) and **P8** (X=O) in water (A, B) and in TFE (C). Hydrogen bonding schemes in [l]{.smallcaps}-*Hyp*~9~ (**P8**) (D) PPII form in water with C4-*endo* proline pucker by intraresidue H-bonding and (E) β-structure in TFE with C4-*exo* proline pucker by interchain H-bonding.](ao0c02826_0008){#fig7}

As already observed, the enantiomeric *cis* polypeptide [d]{.smallcaps}~C~-*Amp*~~9~~ (**P8**) exhibits CD spectra corresponding to the right-handed PPII form in aqueous phosphate buffer and the β-sheet-like structure (left-handed) in TFE. The CD spectra of *cis* peptide [l]{.smallcaps}~C~-*Amp*~~9~~(**P3**) recorded in other hydrophobic solvents such as methanol and acetonitrile show formation of β-structures ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). These results imply the generality of the β-structure of *cis*-4-(NH~2~/OH)-substituted homochiral [l]{.smallcaps}/[d]{.smallcaps}-prolyl polypeptides in solvents that are more hydrophobic than water. The formation of β-structure in these peptides (**P3** and **P8**) is facilitated by a flip at C4 in proline puckering to place the 4-substituent in a more accessible pseudo-equatorial position ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}C). Although there is no direct proof for this structure at this time, it has been reported earlier that poly-isoleucine, which shows α-helix in aqueous solvents, switches to a β-conformation in TFE caused by low dielectric constant and steric effects of the solvent.^[@ref44]^

The slight asymmetry in the mirror images of CD spectra observed for enantiomeric 4-substituted prolyl derivatives (but not in unsubstituted [l]{.smallcaps}- and [d]{.smallcaps}-proline) for β-structures in TFE is surprising, but it has some literature precedence in enantiomeric linear peptides.^[@ref45]^ The conformational preferences in polyproline peptides are governed by an intricate balance among the nature of 4-substituent, stereoelectronic factors, gauche effects (N1-C^4^H), and n−π\* interactions.^[@ref29],[@ref38]^ A stereoinversion at C2 ([l]{.smallcaps} to [d]{.smallcaps}) might differentially affect such nonbonded secondary interactions, which may not necessarily translate into mirror image effects, particularly in five-membered puckered systems. Only one report exists on linking n−π\* interactions to chirality at C2 in prolines from a study of five diastereomeric sets of 4*R*-substituted proline monomers from available crystal structure data.^[@ref46]^ The results suggest that n−π\* interactions can induce pyramidalization of C2 carbonyl, creating a stereogenic center at the carbonyl carbon through electronic delocalization. Being adjacent to an existing chiral center at C2 ([l]{.smallcaps}/[d]{.smallcaps}), such induced chiral effects from n−π\* interactions in monomers additively build up in proline oligomers and further reinforced by chirality of C4 substituents. This enantiomer-specific effect may contribute to imparting some nonmirror image profiles in CD spectra of enantiomeric pairs. It is also known that the major contributions to CD spectra of peptides are from the backbone secondary structure with minor contributions from side chains. The fact that unsubstituted [l]{.smallcaps}- and [d]{.smallcaps}-prolyl polypeptides show exact mirror images but not the 4-substituted [l]{.smallcaps}/[d]{.smallcaps}-prolyl peptides suggests that the observed distortion from ideal mirror image CD profiles may originate from nonbonding interactions of 4(*R*/*S*)-substituents.

It may be recalled that way back in 1953, Linus Pauling had proposed that polypeptide chains possessing alternate [l]{.smallcaps}- and [d-]{.smallcaps}amino acids can give rise to rippled sheet structures.^[@ref47]^ It was later found that helices from peptides with alternating [l]{.smallcaps}- and [d]{.smallcaps}-amino acids have torsional angles in relevant β-regions of the Ramachandran plot and form either single- or double-stranded helices.^[@ref48],[@ref49],[@ref36],[@ref37],[@ref50]^ In this background, the β-structure observed for the alternating heterochiral peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) in TFE resembling that of [d]{.smallcaps}-*cis* peptide [d]{.smallcaps}~C~-*Hyp*~9~ (**P8**) is in conformity with the predictions of Pauling and substantiates the projections from the Ramachandran plot.^[@ref48]^

Morphology of Self-Assembled 4(*R*/*S*)-Amino-[l]{.smallcaps}/[d]{.smallcaps}-prolyl Polypeptides {#sec2.6}
-------------------------------------------------------------------------------------------------

It was previously observed that the conformation adopted in solution manifested in the self-assembly-induced morphology as seen by field emission scanning electron microscopy (FESEM) images.^[@ref25]^ The PPII conformation of *Hyp* polypeptides in buffer led to spherical nanoparticles, while the β-like structure resulted in long twisted nanofibers.^[@ref25]^[Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"} shows FESEM and atomic force microscopy (AFM) images of the enantiomeric pairs [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**). Both peptides in water showed irregular aggregates of random shapes ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}A,D), while in TFE, they self-assembled into nice long twisted fibrous structures ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}B,E) with a helical pitch of around 80 nm and a width of 15--20 nm. The individual fibrils intertwined around each other to form longer and thicker fibers up to 60 nm in width and several micrometers in length ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information), similar to protofilaments of amyloid fibers.^[@ref51]^ The left-handed helical nature of the individual fibrils was retained in fibers and strongly pronounced during the hierarchical assembly. The AFM images ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}C,F) revealed heights of nanofibrils to be 2--3 nm ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information), suggesting stacks of the polypeptides in fibrils with some particles still bound to fibers.

![Morphology of the all-*cis* peptides [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**). FESEM micrographs of peptide **P3** in water (A) and TFE (B). FESEM micrographs of peptide **P8** in water (D) and TFE (E). AFM images of peptides **P3** (C) and **P8** (F) in TFE.](ao0c02826_0009){#fig8}

Contrary to expectations, the nanofibers from enantiomeric homochiral peptides [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) exhibited similar left-handed helical twists in the FESEM images ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}B,E). Thus, although in TFE solution the enantiomeric polypeptides exhibited opposite helicity ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C), it was not translated into the self-assembled morphological forms.^[@ref52]^ Both polypeptides displayed an inherent preference for left-handedness in the formation of supramolecular twisted fibers. The peptides [l]{.smallcaps}~T~-*Amp*~~9~~ (**P2**) and [d]{.smallcaps}~T~-*Amp*~~9~~ (**P7**) that failed to show β-structure in TFE solution formed nanoparticles of random shapes in both water and TFE ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). Similarly, nanofibrous morphology was found to be inaccessible to unsubstituted [l]{.smallcaps}-*Pro*~9~ (**P1**) and [d]{.smallcaps}-*Pro*~9~ (**P6**) peptides ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). Although anisotropic straw- or spindle-like structures were observed, the morphologies of [l]{.smallcaps}-*Pro*~9~ (**P1**) and [d]{.smallcaps}-*Pro*~9~ (**P6**) were distinctly different from those of well-defined nanofibers formed by [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**). Thus, the discrete nanoparticles seen in FESEM images corroborated with the PPII conformation seen in solution and nanofibers with a β-like structure in solution, underlining the role of peptide secondary structures in dictating the morphology of the supramolecular assemblies.

![FESEM micrographs of *trans* peptides. [l]{.smallcaps}~T~-*Amp*~~9~~ (**P2**) in (A) water and (B) TFE. [d]{.smallcaps}~T~-*Amp*~~9~~ (**P7**) in (C) water and (D) TFE.](ao0c02826_0010){#fig9}

To test if the supramolecular associations arise from the natural assembly process in solution or consequences of aggregation during solvent evaporation on a surface, dynamic light scattering (DLS) data in buffer was recorded for [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) in solution ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). The data indicated a size distribution of 100--500 nm particles in TFE, which was absent in water. The peptide [l]{.smallcaps}~T~-*Amp*~~9~~ (**P2**) that did not form β-structures in TFE, showed the absence of large size particles in both water and TFE. This suggested self-assembly of *cis* peptide [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) only in TFE, and in the case of [l]{.smallcaps}~T~-*Amp*~~9~~ (**P2**), no such assemblies were noticed in both water and TFE. Thus, the conformation seen from CD in solution very well correlates with images seen in FESEM.

### Effect of Concentration on Morphology of [l]{.smallcaps}~C~-Amp~~9~~ (**P3**) in TFE {#sec2.6.1}

Since self-assembly is promoted at higher concentrations, FESEM images of *cis* peptide [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) in TFE were recorded at increasing concentrations (2 μM, 50 μM, 100 μM, 150 μM, 200 μM, and 2 mM) after incubation for 12 h. At a low concentration of 2 μM, **P3** formed spherical and elongated structures of \<100 nm in width ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}A), and at 50 μM concentration, fibers emerged along with spherical nanoparticles ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}B). In the concentration range 100--200 μM, nanofibers became more prominent ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}C--E), and at 2 mM, well-defined fibrils of lengths in the range 1--3 μm formed with good dispersion. These results illustrate that while the assembly of the peptide strands is stunted at low concentrations (2--50 μM) to spherical or irregular nanoparticles, they grow into helical nanofibers at higher concentrations (50 μM to 2 mM).

![FESEM images of morphologies formed by peptide [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) in TFE at different concentrations: (A) 2 μM, (B) 50 μM, (C)100 μM, (D)150 μM, (E) 200 μM, and (F) 2 mM. Images were recorded after an incubation period of 12 h.](ao0c02826_0011){#fig10}

### Time-Dependent Changes in the Morphology of [l]{.smallcaps}~C~-Amp~~9~~ (**P3**) {#sec2.6.2}

To examine if the initially formed smaller nanoparticle under kinetic control evolves into thermodynamically more stable nanofibers, the self-assembly of [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) at 200 μM concentration was recorded by FESEM as a function of time. After incubation for 1 h, the peptide showed uniform spherical particles of 20--100 nm ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}A), aligned along the thin fibrous axis. After 6 h, the nanofibers emerged along the axis through fusion and superposition of initially formed nanoparticles by mass transfer ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}B). After 12 h, the spherical particles completely vanished with conversion into fully grown nanofibers ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}C). The observed time-dependent changes in FESEM images pointed out that the early emerging spherical particles are a product of the self-assembly process under initial kinetic control, which over a period of 12 h slowly transformed into thermodynamically more stable helical nanofibrous structures, similar to those reported in the literature.^[@ref53]^ The nanofibers even at \<6 h were already helical, indicating that the development of helical twists of the fibers was synchronous with fibers spinning out of the spherical particles rather than development at a later stage after fiber formation.

![FESEM images of growth of nanofibers of peptide [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) in TFE at different incubation times: (A) 1 h, (B) 6 h, and (C) 12 h. The concentration of the peptide was 200 μM.](ao0c02826_0012){#fig11}

### Self-Assembly of the Enantiomeric Mixture of [l]{.smallcaps}~C~-Amp~9~ (P3) and [d]{.smallcaps}~C~-Amp~9~ (**P8**) {#sec2.6.3}

The enantiomeric peptides [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~9~ (**P8**) show mirror image CD profiles in aqueous phosphate buffer and TFE, but their supramolecular assembly into nanofibers displayed same handedness and helical twist. To probe their co-assembly, the two enantiomeric peptides [l]{.smallcaps}~C~*-Amp*~9~ (**P3**) and [d]{.smallcaps}~C~*-Amp*~9~ (**P8**) were mixed in 1:1 molar ratio and FESEM images of the mixture are shown in [Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}. Interestingly, the enantiomeric blend exhibited nanofibers with larger thickness (∼40 nm width) compared to that of individual fibers (20 nm width) accompanied by tighter winding of the helix. The helical twist remained left-handed as in the constituent peptides ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}). This is perhaps a consequence of the same handedness of enantiomeric peptides, facilitating further winding of nanofibers around each other and reinforcing the formation of a thicker fiber with a tighter twist.

![Morphology of nanofibers of the enantiomeric mixture of Lc-*Amp*~9~ (**P3**) and Dc-*Amp*~9~ (**P8**) in TFE. (A) [l]{.smallcaps}-Peptide Lc-*Amp*~9~ (**P3**). (B) 1:1 mixture of the peptide enantiomers, Lc-*Amp*~9~ (**P3**) and Dc-*Amp*~9~ (**P8**). (C) [d]{.smallcaps}-Peptide Dc-*Amp*~9~ (**P8**).](ao0c02826_0013){#fig12}

Self-Assembly of [l]{.smallcaps}-*Hyp*~9~ and [d]{.smallcaps}-*Hyp*~9~ Polypeptides {#sec2.7}
-----------------------------------------------------------------------------------

The homochiral enantiomeric [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) and [d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) polypeptides in water self-assembled into rice grain-like elongated nanoparticles with size ∼100 nm. However, in TFE, while the enantiomeric [l]{.smallcaps}~C~-*Hyp*~9~ (**P5**) assembled into nanorods of 1 μm length as reported earlier,^[@ref25]^[d]{.smallcaps}~C~-*Hyp*~9~ (**P10**) showed aggregates of disordered particles of 200 nm size ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). Thus, unlike *Amp*~9~ peptides, free *Hyp*~9~ polypeptides in TFE do not form fibers and show nanofiber formation only when they are conjugated with fatty acid chains.^[@ref25]^

The heterochiral alternating \[[l]{.smallcaps}~C~[d]{.smallcaps}~C~\]~4~[l]{.smallcaps}~C~ peptide (**P11**) aggregated in water to form disordered particles of 200 nm size, but in TFE, it formed rods or spindle-shaped aggregates of length 200 nm and width 20 nm ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information) similar to those seen with homochiral [l]{.smallcaps}~C~-*Hyp*~9~ polypeptides.^[@ref25]^ The heterochiral *trans* peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**), which showed a left-handed PPII helix in aqueous phosphate buffer, self-assembled to form nanospheres of ∼200 nm diameter. In TFE, it exhibited short nanorods of length ∼200 nm and width 20--30 nm ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information). Since chemical conjugation to fatty acid at the N-terminus of the peptide has been shown to promote β-structures exhibiting homochiral [l]{.smallcaps}~C~-*Hyp*~9~ to assemble into nanofibers in TFE,^[@ref25]^ the peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) was conjugated with C14 fatty acid and, its self-assembly in TFE was examined. The peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) displayed nanofibrous morphology ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}C), with nanofibers around 2--3 μm in length and 20 nm in height with a left-handed twist generating grooves with depth around 4--6 nm ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}D).

![FESEM images of alternating peptide \[[l]{.smallcaps}~T~[d]{.smallcaps}~T~\]~4~[l]{.smallcaps}~T~ (**P12**) conjugated with fatty acid (C~14~) (A) in water and (C) in TFE. AFM images of **P12** (B) in water and (D) in TFE. Insets in (B) and (D) show the height profiles of the nanostructures.](ao0c02826_0014){#fig13}

Conformation vs Morphology {#sec2.8}
--------------------------

The observed β-structure in TFE for the cis-4-substituted [l]{.smallcaps}/[d]{.smallcaps}-prolyl polypeptides correlates well with the self-assembly of these peptides into nanofibers^[@ref24],[@ref25],[@ref30]^ as seen from the FESEM images. The polypeptides with the PPII form assemble into irregular or spherical nanostructures ([Figures [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}A,D and [9](#fig9){ref-type="fig"}A,C) in buffer. When the peptides are dissolved in TFE, hydrophobic desolvation of the peptide side chain and backbone leads to favorable formation of an interdigitated interchain H-bonding network (side chain to backbone) ([Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}),^[@ref54]^ resulting in β-structures with a chiral twist to form nanofibrils that associate into macroscopic fiber bundles.

![Possible mechanism of self-assembly of [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**).](ao0c02826_0015){#fig14}

The morphological changes observed in the time-dependent FESEM studies suggest an interplay between kinetic and thermodynamic factors involved in the supramolecular assembly of Lc-*Amp*~~9~~ (**P3**).^[@ref53]^ The intermolecular H-bonding interactions between peptide chains to form β-structures possibly trigger a kinetically favored nucleation process, resulting in the rapid formation of irregular achiral spherical aggregates within first 1 h. These spherical aggregates transform into thermodynamically stable supramolecular helical fibrils, which further combine laterally and extend along the axis to form larger fibers and subsequently into bundles over a period of 12 h ([Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}). Only the *cis* peptides [l]{.smallcaps}~C~-*Amp*~~9~~ (**P3**) and [d]{.smallcaps}~C~-*Amp*~~9~~ (**P8**) exhibiting β-structures in TFE form nanofibers. The unsubstituted polyproline peptides [l]{.smallcaps}-*Pro*~~9~~ (**P1**) and [d]{.smallcaps}-*Pro*~~9~~ (**P6**) and the *trans* peptides [l]{.smallcaps}~T~-*Amp*~~9~~ (**P2**) and [d]{.smallcaps}~T~-*Amp*~~9~~ (**P7**)\] with no potential for β-structures do not self-assemble into nanofibers. On a similar line, we have recently reported that speigelmeric collagen peptides constituting *trans*-(4*R*)-amino-[l]{.smallcaps}-proline and *trans*-(4*S*)-amino-[d]{.smallcaps}-proline that assume left- and right-handed PPII helical forms, respectively, self-assemble into achiral spherical nanostructures^[@ref27]^ but not into nanofibers. This observation emphasizes the importance of stereospecific cis disposition of H-bonding C2 and C4 substituents on proline to favor β-structures in TFE and enable helical self-assembly in homochiral peptides.

The twist in the backbone of β-strands plays a critical role in determining the chirality of supramolecular fibrous helical assemblies.^[@ref55]^ Peptides with an intrinsic right-handed twist assemble into left-handed helical nanofibers.^[@ref34],[@ref51],[@ref52],[@ref55]^ Generally, the naturally occurring [l]{.smallcaps}-peptides exhibit a right-handed backbone twist, and several amyloid proteins and peptides are known to form left-handed helical assemblies.^[@ref56]^ Peptides composed of [d]{.smallcaps}-amino acids show helical assemblies with right-handed helicity, opposite of their [l]{.smallcaps}-counterpart.^[@ref57]^ Nature employs proline-rich regions to prevent fibrillation of proteins.^[@ref58]^ Introduction of a stretch of polyprolines in proteins was found to reduce the tendency of the protein to form β sheets, thereby reducing the chances of their aggregation into amyloidogenic fibers.^[@ref58]^ Interestingly, while unsubstituted polyprolines adopt the PPII form, which prevents fibrillation, stereospecific C4(*S*)-NH~2~/OH substitution favors fibrillation in TFE through formation of a β-structure-like conformation.

Conclusions {#sec3}
===========

The unique conformational and self-assembling features of 4(NH~2~/OH)-substituted *cis*-(2*S*,4*S*)-[l]{.smallcaps}-prolyl (**P3**) and *cis*-(2*R*,4*R*)-[d]{.smallcaps}-prolyl (**P8**) polypeptides reveal that mirror image PPII and β-structures were adopted by the enantiomeric peptides as seen by CD spectra. However, these were not perfect mirror images unlike those of unsubstituted [l]{.smallcaps}/[d]{.smallcaps}-prolyl enantiomeric pairs **P1**/**P6**. The observed slight asymmetry in band positions and intensities in CD spectra of enantiomeric peptides reveal that the substitution at C4 with an amino group leads to subtle changes at microstructural levels among the enantiopairs, perhaps induced by nonbonded interactions. The PPII form in aqueous buffer self-assembles to spherical nanoparticles as visualized by FESEM, while the β-structure, adopted in TFE, results into nanofibers in TFE. However, the opposite helical handedness of peptide PPII helices in aqueous phosphate buffer or β-structure in TFE does not translate into self-assembled nanofibers that were similar for both enantiopairs. The peptide [l]{.smallcaps}~C~-*Amp*~9~ (**P3**) initially assembles into kinetically favored aggregates from which thermodynamically stable helical nanofibers are spun out over a period of 12 h, followed by further hierarchical assembly to form larger bundles. The present study highlights the significance of C4-substitutents on proline in determining the strength of intermolecular interactions, which directs the self-assembly of this class of peptides. The results have implications for understanding how different conformations of peptides in solution drive self-assemblies toward specific nanostructures.

The future potential applications of the work may involve generation of nanofibers of the peptides from TFE to explore their application as water-sensitive organogels.^[@ref59]^ Given the remarkable way the supramolecular chirality is delinked from the chirality of the peptide building block, it will be interesting to study chirality induction properties of homo and heterochiral polyproline peptides on immobilized metal nanoparticles. The conformational transition (PPII to β) of these peptides can be integrated into dynamic nanosystems that reconfigure in response to the hydration levels of the environment. Further, as cationic peptides, *Amp*~9~ peptides are analogues of poly-[l]{.smallcaps}-lysine that are used to functionalize surfaces for promoting cell adhesion.^[@ref60]^ The cross-linked polyaminoprolyl peptides could thus be useful in surface functionalization for material and tissue engineering applications. The cell penetrating and membrane disrupting properties of these peptides are being explored for potential use as antimicrobial peptides.^[@ref61]^

Experimental Methods {#sec4}
====================

General Procedures {#sec4.1}
------------------

All starting materials and reagents used were of the highest grade available commercially and were used without further purification. Reactions were monitored by thin-layer chromatography (TLC) using silica gel 60 F~254~ plates. Compounds on TLC were visualized by UV and by ninhydrin spray. All column chromatography purifications were performed using 100--200 mesh silica gel as the stationary phase. ^1^H and ^13^C NMR spectra were recorded on Bruker 400 MHz in CDCl~3~, and chemical shifts in δ parts per million (ppm) were referenced to tetramethylsilane (TMS). High-resolution mass spectrometry (HRMS) was used in electrospray ionization time of flight (ESI-TOF) mode to measure the exact mass of the compounds. The molecular weights of all of the peptides were characterized by matrix-assisted laser desorption and ionization time of flight (MALDI-TOF) spectrometry operated in positive reflection mode using either α-cyano-4-hydroxy cinnamic acid (CHCA) or 2,5-dihydroxy benzoic acid (DHB) as matrix.

Synthesis of Compounds **6**, **10**, **12**--**15** {#sec4.2}
----------------------------------------------------

### (4*S*)-(*p*-Toluenesulfonyloxy)-*N*^1^-(Cbz)-[d]{.smallcaps}-proline Methyl Ester **12** {#sec4.2.1}

The compound **11** (1.2 g, 4.3 mmol), PPh~3~ (1.35 g, 5.1 mmol), and methyl *p-*toluenesulfonate (0.8 mL, 5.1 mmol) were dissolved in dry THF (10 mL) and cooled to 0 °C on ice bath under nitrogen. The mixture was stirred for 30 min at 0 °C. Diethyl azodicarboxylate (0.8 mL, 5.1 mmol) was added slowly with a syringe. The reaction mixture was stirred at 0 °C for first 4 h and then stirred at room temperature for 8 h, after which THF was removed under reduced pressure. The resulting orange thick oil was dissolved in ethyl acetate (10 mL) to which petroleum ether (100 mL) was added and triturated with the spatula; then, the solution was kept at room temperature for 2 h. The white powder settled down was filtered, and then the filtrate was concentrated on a rotatory evaporator and purified by column chromatography. Yield: 1 g, 56%; (SiO~2~, 30% ethyl acetate/hexane); specific rotation: \[α\]~D~^25^ +4 (*c*, 2%, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 7.77--7.28 (9H, m), 5.19--4.96 (3H, m), 4.52--4.40 (1H, m), 3.72--3.67 (3H, m), 3.60--3.50 (3H, m), 2.44--2.31 (4H, m); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 171.6, 154.4, 136.2, 130.2, 130.0, 128.9, 128.2, 128.1, 127.8, 67.5, 67.1, 57.6, 56.6, 52.5, 51.7, 37.2, 36.1, 29.7, 21.7; IR (neat, cm^--1^) 3022, 2957, 1747, 1709, 1599, 1419, 1357, 1213, 1177, 1114, 1053,1013; HRMS (ESI-TOF) *m*/*z*: \[M + Na\]^+^ calcd for C~21~H~23~NO~7~SNa 456.1092; found 456.1087.

### (4*R*)-Azido-*N*^1^-(benzyloxycarbonyl)-[d]{.smallcaps}-proline Methyl Ester **13** {#sec4.2.2}

The compound **12** (0.8 g, 1.8 mmol) and NaN~3~ (1.4 g, 22 mmol) were dissolved in dry DMF (20 mL) and stirred for 8 h at 60 °C under a nitrogen atmosphere. After completion of reaction, DMF was removed under reduced pressure and the residue was dissolved in water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous Na~2~SO~4~, and concentrated on a rota-evaporator to yield colorless thick oil. The crude product obtained was purified by column chromatography. Yield: 0.4 g, 71%; (SiO~2~, 20% ethyl acetate/hexane); specific rotation: \[α\]~D~^25^ +17 (*c*, 2%, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 7.38--7.27 (m, 5H), 5.13 (ddd, *J* = 33.8, 16.9, 7.7 Hz, 2H), 4.46 (ddd, *J* = 26.2, 8.9, 3.6 Hz, 1H), 4.18 (dqd, *J* = 7.4, 3.7, 1.7 Hz, 1H), 3.89--3.59 (m, 1H), 3.61--3.47 (m, 4H), 2.53--2.35 (m, 1H), 2.22 (dt, *J* = 13.5, 3.5 Hz, 1H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 171.0, 154.6, 154.2, 136.0, 128.6, 128.2, 67.5, 59.5, 58.3, 57.8, 52.5, 51.2, 35.5, 35.0; IR (neat, cm^--1^) 2954, 2104, 1747, 1701, 1413, 1347, 1267, 1203, 1169, 1112, 1056; HRMS (ESI-TOF) *m*/*z*: \[M + Na\]^+^ calcd for C~14~H~16~N~4~O~4~Na 327.1069; found 327.1072.

### (4*R*)-*N*^4^-(*t*-Boc)-*N*^1^-(Cbz)-[d]{.smallcaps}-proline Methyl Ester **14** {#sec4.2.3}

The azido compound **13** (4 g, 12.5 mmol) was reacted with PPh~3~ (5 g, 19.2 mmol) in dry THF (40 mL). The resulting solution was stirred overnight; when complete consumption of azide was observed, then water (4 mL) was added followed by stirring for another 2 h and THF was evaporated under reduced pressure to yield the crude amine product. The residue was dissolved in dioxane--water (1:1) containing NaHCO~3~ followed by slow addition of (Boc)~2~O (3.45 g, 16 mmol) and stirred for another 4 h. After completion of reaction, the reaction mixture was concentrated and extracted with ethyl acetate and purified by column chromatography to obtain **14**. Yield: 2.0 g, 41%; (SiO~2~, 15% ethyl acetate/hexane); specific rotation: \[α\]~D~^25^ +9 (*c*, 2%, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 7.36--7.26 (m, 5H), 5.09 (dt, *J* = 21.6, 12.3 Hz, 2H), 4.36 (ddd, *J* = 20.9, 9.6, 3.0 Hz, 2H), 3.85--3.55 (m, 4H), 3.51 (dd, *J* = 22.8, 10.4 Hz, 1H), 2.46 (tdd, *J* = 13.5, 9.7, 6.3 Hz, 1H), 2.08--1.89 (m, 1H), 1.41 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 174.1, 155.2, 154.8, 154.1, 136.3, 128.6, 128.5, 128.1, 127.9, 67.5, 58.0, 57.7, 52.7, 52.5, 37.0, 35.9, 28.4; HRMS (ESI-TOF) *m*/*z*: \[M + Na\]^+^ calcd for C~19~H~26~N~2~O~6~Na 401.1688 found 401.1689.

### (4*R*)-*N*^4^(*t*-Boc)-*N*1(Fmoc)-[d]{.smallcaps}-aminoproline **6** {#sec4.2.4}

Compound **14** (1 g, 4.3 mmol) was hydrolyzed in THF/water (1:1, 20 mL) using LiOH 2 N, for 1 h. THF was removed under vacuum, and the aqueous layer was washed with ethyl acetate, acidified with aq KHSO~4~, and extracted with ethyl acetate to obtain the crude product (acid). The crude product obtained was dissolved in dry methanol (15 mL) and hydrogenated in the presence of 10% Pd/C (0.5 g) for 6 h. The reaction mixture was filtered through celite. The filtrate was concentrated under reduced pressure. The product obtained as a white solid powder was dissolved in water/dioxane, 1:1 (60 mL). This was treated with 10% Na~2~CO~3~ at 0 °C to bring to pH 9.0 and stirred for 30 min. Fmoc-Cl (1.4 g, 5.6 mmol) was added portionwise over a period of 45 min maintaining the temperature at 0 °C for first 4 h and then allowing to come to room temperature and stirred for 18 h. After completion of the reaction, the mixture was acidified with aq KHSO~4~ to pH 4.0 and followed by work up to obtain the crude product, which was then purified by column chromatography. Yield: 1 g, 53%; (SiO~2~, 1.5% methanol/dichloromethane (DCM)); specific rotation: \[α\]~D~^25^ +3 (*c*, 2%, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 7.76 (dd, *J* = 11.8, 7.5 Hz, 2H), 7.58 (dd, *J* = 13.6, 7.4 Hz, 2H), 7.47--7.29 (m, 4H), 5.34 (d, *J* = 17.9 Hz, 1H), 4.48 (dd, *J* = 22.5, 12.4 Hz, 2H), 4.29 (dd, *J* = 24.8, 18.0 Hz, 2H), 3.71 (d, *J* = 17.7 Hz, 1H), 3.55 (d, *J* = 11.1 Hz, 1H), 2.42 (ddd, *J* = 15.5, 9.4, 6.4 Hz, 1H), 2.35--2.10 (m, 1H), 1.49 (d, *J* = 18.3 Hz, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 174.2, 155.2, 155.3, 143.8, 141.1, 141.2, 127.8, 127.1, 125.9, 124.9, 120.0, 79.8, 68.6, 53.7, 53.3, 50.0, 29.3, 47.1; IR (neat, cm^--1^) 3337, 3016, 2978, 1691, 1516, 1421, 1356, 1247, 1213, 1164, 1120, 1075, 1011; HRMS (ESI-TOF) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~28~N~2~NaO~6~Na 475.1845; found 475.1850.

### (2*R*,4*R*)-*N*^1^-((Benzyloxy)carbonyl)-4(*tert*-butoxy)-hydroxyproline Ester **15** {#sec4.2.5}

The mixture of compound **11** (5.0 g, 179 mmol), Ag~2~O (8.5 g 358 mmol), and *tert*-butyl bromide (6 mL, 537 mmol) in cyclohexane (50 mL) was stirred for 24 h at room temperature. The resulting suspension was filtered out, the filtrate was concentrated under reduced pressure, and the crude product was purified by silica gel chromatography eluting with petroleum ether/ethyl acetate (80:20) to give a desired product **15**. Yield: 5.11 g, 85%; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.35--7.24 (m, 5H), 5.18--5.01 (m, 2H), 4.37--4.32 (m, 1H), 4.15--4.12 (m, 1H), 3.74--3.56 (m, 4H), 3.34--3.30 (m, 1H), 2.34--2.28 (m, 1H), 2.06--2.02 (m, 1H), 1.13 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 172.7, 172.5, 154.9, 154.4, 136.7, 136.5, 128.5, 128.1, 128.0, 127.9, 74.0, 69.4, 68.6, 67.2, 67.1, 57.8, 57.5, 53.6, 53.4, 38.8, 37.9, 28.3; HRMS (ESI-MS) *m*/*z*: \[M + Na\]^+^ calcd for C~18~H~25~NO~5~ 358.1630; found 358.1629.

### (2*R*,4*R*)-*N*^1^-((Fmoc)carbonyl)-4(*tert*-butoxy)-hydroxyproline **10** {#sec4.2.6}

Compound **15** (1.5 g, 4.7 mmol) was dissolved in dry methanol (15 mL), to which 10% Pd/C (0.2 g) was added. The mixture was subjected to hydrogenation under H~2~ gas. Water (200 mL) was added to the reaction mixture, which was filtered through filter paper, and the filtrate was concentrated under reduced pressure. The product obtained as a white solid powder was dissolved in water/dioxane, 1:1 (50 mL). The pH was maintained at 10 by addition of 10% Na~2~CO~3~. The reaction mixture was stirred at 0 °C for 15 min. Fmoc-Cl (1.5 g, 5.6 mmol) was added portionwise for 45 min while maintaining the temperature at 0 °C for first 4 h and then allowed to come to room temperature followed by stirring for 18 h. The dioxane was removed under vacuum, and the aqueous layer was washed with ethyl acetate (3 × 80 mL). The aqueous layer was acidified with 2 N HCl to pH 2 followed by extraction with ethyl acetate (3 × 70 mL). Evaporation of the solvent gave the crude product, which was purified by silica gel chromatography (70% ethyl acetate/hexane) to afford compound **10** as a white solid (1.49 g, 78% yield); \[α\]~D~^25^ +3.6 (*c* 1.0 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~) δ: 7.73--7.24 (m, 8H), 4.50--4.23 (m, 5H), 3.62--3.37 (m, 2H), 2.41--2.33 (m, 1H), 2.21--2.13 (m, 1H), 1.21 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ: 173.7, 143.8, 143.7, 141.4, 127.8, 127.2, 125.4, 125.1, 120.0, 69.6, 69.2, 68.2, 67.9, 58.6, 54.8, 53.9, 47.2, 47.1, 38.2, 37.0, 28.1, 28.0; HRMS (ESI-MS) *m*/*z*: \[M + Na\]^+^ calcd for C~24~H~27~NO~5~ 432.1787; found 432.1786.

Chiral Purity of Monomers by HPLC {#sec4.3}
---------------------------------

The chiral purity of the [d]{.smallcaps}-amino acid monomers **4** and **6** was assessed by comparing their retention times in chiral high-performance liquid chromatography (HPLC) with those of their enantiomers. For this study, an Agilent Technologies 1260 Infinity system equipped with a photodiode array detector (PDA) and a Chiralpak IA-analytical column (Daicel) containing amylose-tris(3,5-dimethyl phenylcarbamate) was used. Mobile phase solutions used were 20% isopropanol and 80% *n*-hexane. The methanolic solutions of the purified monomers were injected, and the retention of the isomers under an isocratic elution method, run at a flow rate of 1 mL/min, was recorded for all of the monomers separately. A mixture of all of the monomers was also co-injected to examine whether the peaks corresponding to different enantiomers resolve.

Solid-Phase Synthesis of Peptides {#sec4.4}
---------------------------------

Peptides were synthesized manually using a sintered reaction vessel equipped with a Teflon stopcock. While the 4-methyl benzhydrylamine (MBHA) resin (100--200 mesh, Novabiochem), available commercially as a hydrochloride salt, was neutralized prior to coupling of the first amino acid desired in the C-terminus of the peptide for the *t*-Boc protocol, the Fmoc group on the Rink amide resin (100--200 mesh, Novabiochem) was removed to prepare it for peptide synthesis using the Fmoc protocol. Coupling reactions were carried out using the in situ active ester method, by HBTU as a coupling reagent, HOBt as a racemization suppresser, and *N*,*N*-diisopropylethylamine (DIPEA) as a catalyst. For *t*-Boc strategy, 50% trifluoroacetic acid (TFA) in DCM was used as a deprotection solution, while 20% piperidine in DMF was used to deprotect the terminal amine groups at the growing end of the peptide in the Fmoc protocol. The N-terminus of the peptides was capped by reaction with acetic anhydride in dry pyridine. The peptides were cleaved from the MBHA resin using trifluoromethanesulfonic acid (TFMSA) in the presence of thioanisole as scavengers and from the Rink amide resin using 95% TFA in DCM in the presence of triisopropyl silane (TIPS) as a scavenger.

Peptide Purification and Characterization {#sec4.5}
-----------------------------------------

The crude peptides **P1**--**P13** were purified by reverse-phase high-performance liquid chromatography (RP-HPLC) on an Agilent Technologies 1260 Infinity system equipped with a photodiode array detector (PDA) and a semipreparative RP-C18 column (250 × 10 mm^2^, 10 μm). For nonlipidated peptides, the following solutions were used as the mobile phase gradients. Solvent A: 5% CH~3~CN in water; solvent B: 50% CH~3~CN in water. Both the solvents contained 0.1% TFA. A linear gradient of 0--100% B was achieved in 20 min. In the case of lipidated peptides, solvent A was 5% CH~3~CN (with 0.1% TFA) and solvent B was 95% CH~3~CN (with 0.1% TFA). The flow rate was maintained at 3 mL/min (**P2**, **P3**) or 2 mL/min (**P1**, **P4**--**P13**). The elution of the peptides was monitored at 220 nm. The structural integrity of the purified peptides was confirmed by MALDI-TOF mass spectrometry using CHCA or DHB as a matrix. The retention time data in HPLC and MALDI-TOF for peptides are shown in [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf), Supporting Information.

Circular Dichroism Studies {#sec4.6}
--------------------------

Circular dichroism (CD) spectroscopic studies were carried out on a JASCO J-815 CD spectrometer using a quartz cuvette of 1 mm path length. Each spectrum was an average of three scans recorded with a bandwidth of 1 nm, a scan speed of 100 nm/min, and a response time of 1 s. The peptide samples were prepared in phosphate-buffered saline (PBS; 10 mM containing 10 mM NaCl, pH 7) at least 24 h prior to measurements and allowed to stand at room temperature (ca. 25 °C). High tension (HT) was maintained below 600 V for all of the CD spectra measured. Representative HT vs wavelength plots for some of the peptides are shown in [Figure S10](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf).

Field Emission Scanning Electron Microscopy Studies {#sec4.7}
---------------------------------------------------

FESEM imaging was performed using a Zeiss ULTRA Plus scanning electron microscope operating at 3 kV. To avoid the morphology of the self-assembled peptides from being obscured by the salts from the buffer, we used Milli-Q water for scanning electron microscopy (SEM) imaging. Calculated amounts of peptides were dissolved in the desired solvent (water or TFE) and allowed to stand for at least 12 h at room temperature (ca. 25 °C). An aliquot of 2 μL of the peptide solution was then drop-casted on a clean silicon wafer. Samples were allowed to dry at room temperature in vacuum desiccators for at least 12 h, and the dried film was sputter-coated with gold prior to imaging.

Atomic Force Microscopy Studies {#sec4.8}
-------------------------------

Atomic force microscopy imaging was carried out on a Keysight 5500 atomic force microscope in tapping mode. The cantilever was auto-tuned at 190 kHz frequency prior to measurements. The desired peptide sample (5 μL) was spotted on a freshly cleaved mica surface and allowed to dry at room temperature (ca. 25 °C) under vacuum for about 12 h before imaging in air.

Dynamic Light Scattering Studies {#sec4.9}
--------------------------------

The particle size distributions were studied by dynamic light scattering (DLS) with Zetasizer Nano ZS-90, Malvern Instruments, equipped with a 633 nm red laser (at 90° angle). Samples were prepared in the appropriate solvent and left to stand for 1 h prior to measurements. Three measurements were carried out for each sample. All of the measurements were recorded at 25 °C. Each measurement consisted of eight runs with data collected for 30 s in each run. An average of three measurements was used for particle size distribution analysis.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c02826](https://pubs.acs.org/doi/10.1021/acsomega.0c02826?goto=supporting-info).Characterization data (NMR and MS of all new compounds, chiral HPLC of monomers, RP-HPLC and MALDI-TOF of all peptides) and DLS, CD, FESEM, and AFM images of peptides ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02826/suppl_file/ao0c02826_si_001.pdf))
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